Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Biochemical and cytogenetic effects of Imazethapyr on Cicer arietinum L.

Manijeh Hoseiny Rad, Ali Ashraf Aivazi.




Abstract
Cited by 2 Articles

Weeds are a serious obstacle to the production of chickpea. Imazethapyr (IM) herbicide is used to control weeds in most of pulses including chickpea. Mitotic abnormalities, chromosomal behavior and protein content in chickpea (Cicer arientinum L.), due to IM treatment, were studied. The Chickpea seeds (variety JG-11) were germinated in sterilized Petri dishes, 9cm in diameter, on Whatmann filter-paper moistened with 10 mL of either Hoagland nutrient solution (control) or five concentrations of IM (0.5, 1, 2.5, 5, and 10 ppm ). From the cytologic point of view, observations demonstrated that the mitotic frequency in root meristematic cells diminished, and that abnormality frequency increased parallel to the increase in concentrations of IM. The herbicide was highly mito-inhibitory and induced chromosomal irregularities, such as stickiness, lagging, scattering, and chromosome bridges. The endosperm and root-shoot axis’ protein content decreased with increasing of the herbicide concentration in all treatments. It can be argued that IM produces undesirable side effects during mitosis in chickpea’s somatic cells and biochemical parameters.

Key words: Herbicide, chickpea, Chromosomal disorder, protein






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.